Scholarlink

Background <p>The N6-Methyladenosine (m6A) RNA modification critically regulates cancer biology, and tertiary lymphoid structures (TLSs) shape antitumor immunity. However, their combined prognostic roles in lung adenocarcinoma (LUAD) remain unclear. This study applies an integrative multi-omics approach to construct an m6A- and TLS-related prognostic model and uncover underlying molecular mechanisms.</p> Methods <p>We identified m6A and TLS-related genes (MTGs) associated with LUAD and constructed a prognostic model using machine learning, which was validated with nomograms. Subsequent analyses included immune microenvironment profiling, tumor mutational burden (TMB), enrichment assays, drug sensitivity testing, and single-cell RNA sequencing (scRNA-seq). The expression of MTGs was detected using quantitative reverse transcription polymerase chain reaction (RT-qPCR).</p> Results <p>The risk model we developed demonstrated strong prognostic value, with areas under the curve (AUCs) exceeding 0.8 at 1, 3, and 5 years. The prognosis of the high-risk cohort (HRC) was significantly worse (<i>P</i> &lt; 0.001). A nomogram incorporating this risk model (AUC = 0.825) outperformed one without it. TMB analysis revealed a higher TMB in the HRC, which is likely associated with a poorer prognosis. Drugs targeting the microtubule dynamics and apoptosis pathways showed increased efficacy in the HRC. Enrichment analysis indicated that the MTGs are primarily involved in cell adhesion, immune response, hematopoietic cell lineage, and cell cycle regulation. The scRNA-seq analysis further revealed that these 8 MTGs are predominantly expressed in fibroblasts and T/NK cell clusters, indicating their possible involvement in regulating local immune responses. RT-qPCR analysis confirmed the differential expression of MTGs.</p> Conclusions <p>This study demonstrates that the integrative multi-omics model reveals not only potential therapeutic targets but also new perspectives on LUAD immunogenetics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification and external validation of a prognostic signature based on N6-methyladenosine- and tertiary lymphoid structures-related genes to evaluate survival prognosis and treatment efficacy in lung adenocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月22日

查看全文
  • Xiangbao Yang,
  • Chengwen Zheng,
  • Yinpeng Pan,
  • Shuoming Wu

摘要

Background

The N6-Methyladenosine (m6A) RNA modification critically regulates cancer biology, and tertiary lymphoid structures (TLSs) shape antitumor immunity. However, their combined prognostic roles in lung adenocarcinoma (LUAD) remain unclear. This study applies an integrative multi-omics approach to construct an m6A- and TLS-related prognostic model and uncover underlying molecular mechanisms.

Methods

We identified m6A and TLS-related genes (MTGs) associated with LUAD and constructed a prognostic model using machine learning, which was validated with nomograms. Subsequent analyses included immune microenvironment profiling, tumor mutational burden (TMB), enrichment assays, drug sensitivity testing, and single-cell RNA sequencing (scRNA-seq). The expression of MTGs was detected using quantitative reverse transcription polymerase chain reaction (RT-qPCR).

Results

The risk model we developed demonstrated strong prognostic value, with areas under the curve (AUCs) exceeding 0.8 at 1, 3, and 5 years. The prognosis of the high-risk cohort (HRC) was significantly worse (P < 0.001). A nomogram incorporating this risk model (AUC = 0.825) outperformed one without it. TMB analysis revealed a higher TMB in the HRC, which is likely associated with a poorer prognosis. Drugs targeting the microtubule dynamics and apoptosis pathways showed increased efficacy in the HRC. Enrichment analysis indicated that the MTGs are primarily involved in cell adhesion, immune response, hematopoietic cell lineage, and cell cycle regulation. The scRNA-seq analysis further revealed that these 8 MTGs are predominantly expressed in fibroblasts and T/NK cell clusters, indicating their possible involvement in regulating local immune responses. RT-qPCR analysis confirmed the differential expression of MTGs.

Conclusions

This study demonstrates that the integrative multi-omics model reveals not only potential therapeutic targets but also new perspectives on LUAD immunogenetics.